Atlas Trials

Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome

Clinical trial NCT06570941 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06570941
Sponsor
Synthonics Inc
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Restless Legs Syndrome
Start date
2024-03-01
Primary completion
2024-09-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.